Cargando…

Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center

AIM: To investigate the rate of antibiotic resistance and its main risk factors in a population of patients with diabetic foot infection (DFI) during the COVID-19 pandemic, in comparison with the population of 2019. METHODS: Two hundred and twenty-five patients with DFI were admitted in a tertiary c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caruso, Paola, Maiorino, Maria Ida, Macera, Margherita, Signoriello, Giuseppe, Castellano, Laura, Scappaticcio, Lorenzo, Longo, Miriam, Gicchino, Maurizio, Campitiello, Ferdinando, Bellastella, Giuseppe, Coppola, Nicola, Esposito, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047299/ https://www.ncbi.nlm.nih.gov/pubmed/33845049 http://dx.doi.org/10.1016/j.diabres.2021.108797

Ejemplares similares

When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes
por: Caruso, Paola, et al.
Publicado: (2021)

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
por: Giugliano, Dario, et al.
Publicado: (2021)

SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy
por: Longo, Miriam, et al.
Publicado: (2020)

Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression
por: Maiorino, Maria Ida, et al.
Publicado: (2021)

GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
por: Giugliano, Dario, et al.
Publicado: (2021)

Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues
por: Longo, Miriam, et al.
Publicado: (2022)

Impact of Pituitary Autoimmunity and Genetic Disorders on Growth Hormone Deficiency in Children and Adults
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

Change in Circulating Levels of Endothelial Progenitor Cells and Sexual Function in Women With Type 1 Diabetes
por: Maio, Antonietta, et al.
Publicado: (2022)

European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
por: di Mauro, Gabriella, et al.
Publicado: (2022)

Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes
por: Maiorino, Maria Ida, et al.
Publicado: (2020)

Chronothyroidology: Chronobiological Aspects in Thyroid Function and Diseases
por: Bellastella, Giuseppe, et al.
Publicado: (2021)

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies
por: Longo, Miriam, et al.
Publicado: (2020)

Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study
por: Longo, Miriam, et al.
Publicado: (2020)

Varicocele: An Endocrinological Perspective
por: Bellastella, Giuseppe, et al.
Publicado: (2022)

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off
por: Giugliano, Dario, et al.
Publicado: (2021)

Mediterranean Diet and Thyroid: An Interesting Alliance
por: Bellastella, Giuseppe, et al.
Publicado: (2022)

Different Formulations of Levothyroxine for Treating Hypothyroidism: A Real-Life Study
por: Trimboli, Pierpaolo, et al.
Publicado: (2020)

Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy
por: Longo, Miriam, et al.
Publicado: (2019)

Diabetes and sexual dysfunction: current perspectives
por: Maiorino, Maria Ida, et al.
Publicado: (2014)

Lifestyle modifications and erectile dysfunction: what can be expected?
por: Maiorino, Maria Ida, et al.
Publicado: (2015)

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

Up and down waves of glycemic control and lower-extremity amputation in diabetes
por: Caruso, Paola, et al.
Publicado: (2021)

Exploring the Performance of Ultrasound Risk Stratification Systems in Thyroid Nodules of Pediatric Patients
por: Scappaticcio, Lorenzo, et al.
Publicado: (2021)

Comment on: Wing et al. Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes: Results From an Ancillary Look AHEAD Study. Diabetes Care 2013;36:2937–2944
por: Maiorino, Maria Ida, et al.
Publicado: (2013)

The residual cardiorenal risk in type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Sexual dysfunctions and short-term glucose variability in young men with type 1 diabetes
por: Caruso, Paola, et al.
Publicado: (2021)

Case Report: Post-gastrectomy reactive hyperinsulinemic hypoglicaemia: glucose trends before and after canagliflozin treatment
por: Bellastella, G., et al.
Publicado: (2023)

Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS
por: Scappaticcio, Lorenzo, et al.
Publicado: (2022)

New insights into vitamin D regulation: is there a role for alkaline phosphatase?
por: Bellastella, G., et al.
Publicado: (2021)

Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta‐Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
por: Giugliano, Dario, et al.
Publicado: (2019)

Neuroimmunoendocrinology of SARS-CoV-2 Infection
por: Bellastella, Giuseppe, et al.
Publicado: (2022)

Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects
por: Bellastella, Giuseppe, et al.
Publicado: (2016)

Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?
por: Caruso, Paola, et al.
Publicado: (2020)

Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
por: Giugliano, Dario, et al.
Publicado: (2021)

Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
por: Giugliano, Dario, et al.
Publicado: (2011)

Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
por: Esposito, Katherine, et al.
Publicado: (2014)

A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses
por: Esposito, Katherine, et al.
Publicado: (2015)

The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
por: Giugliano, Dario, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsip290h74n9ld6gp6jtpm0lvd